1-3 of 3
Alexander J. Cole
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy

Available to Purchase
Alexander J. Cole, Santiago Panesso-Gómez, Jaynish S. Shah, Tonge Ebai, Qi Jiang, Ece Gumusoglu-Acar, Maya G. Bello, Anda Vlad, Francesmary Modugno, Robert P. Edwards, Ronald J. Buckanovich
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (10): 1969–1983.
https://doi.org/10.1158/1078-0432.CCR-22-2254
Published: 15 May 2023
View articletitled, Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy
Open the PDF for Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract A06: Cisplatin-induced DNA damage modifies the chromatin landscape of histone H2B monoubiquitination in a p53-dependent manner

Free
Alexander J. Cole, Kristie-Ann Dickson, Christopher Liddle, Clare Stirzaker, Roderick Clifton-Bligh, Deborah J. Marsh
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): A06.
https://doi.org/10.1158/1557-3265.OVCA17-A06
Published: 01 August 2018
View articletitled, Abstract A06: Cisplatin-induced DNA damage modifies the chromatin landscape of histone H2B monoubiquitination in a p53-dependent manner
Journal Articles

Abstract B05: Assessment of TP53 mutation status in primary high-grade serous ovarian cancer and cell line models: Comparison between immunohistochemistry and next-generation sequencing.

Free
Alexander J. Cole, Trisha Dwight, Ying Zhu, Anthony J. Gill, Kristie-Ann Dickson, Adele Clarkson, Gregory B. Gard, Jayne Maidens, Susan Valmadre, Roderick J. Clifton-Bligh, Deborah J. Marsh
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): B05.
https://doi.org/10.1158/1557-3265.OVCA15-B05
Published: 15 January 2016
View articletitled, Abstract B05: Assessment of TP53 mutation status in primary high-grade serous ovarian cancer and cell line models: Comparison between immunohistochemistry and next-generation sequencing.